Viewing Study NCT02354105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-01-09 @ 9:48 PM
Study NCT ID: NCT02354105
Status: COMPLETED
Last Update Posted: 2019-03-11
First Post: 2015-01-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
Sponsor: UCB Biopharma S.P.R.L.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Axial Spondyloarthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Axial Spondyloarthritis View
None Radiographic Axial Spondyloarthritis View
None Non-radiographic Axial Spondyloarthritis View
None Ankylosing spondylitis View
None Diagnosis View
None Cimzia View
None CZP View
None Certolizumab Pegol View
None CDP870 View